Status:
COMPLETED
A Study of Self-administered Misoprostol to Prevent Bleeding After Childbirth in the Community (MamaMiso)
Lead Sponsor:
Gynuity Health Projects
Collaborating Sponsors:
University of Liverpool
Liverpool School of Tropical Medicine
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Postpartum hemorrhage (PPH) is a major cause of maternal death in the developing world. An important strategy in the prevention of deaths is the use of uterotonic drugs for PPH prophylaxis. Misoprosto...
Eligibility Criteria
Inclusion
- pregnant women living in the recruitment villages of Mbale district at \>34 weeks gestation
Exclusion
- Any woman with a known allergy to misoprostol or other prostaglandins will be excluded as will any woman under 18 years old (unless she is an emancipated minor)
Key Trial Info
Start Date :
May 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
749 Patients enrolled
Trial Details
Trial ID
NCT01510574
Start Date
May 1 2012
End Date
October 1 2012
Last Update
March 13 2013
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Busiu Health Centre
Mbale, Mbale, Uganda
2
Lwangoli Health Centre
Mbale, Mbale, Uganda
3
Mbale Regional Referral Hospital
Mbale, Mbale, Uganda
4
Siira Health Centre
Mbale, Mbale, Uganda